William Bertrand
About William Bertrand
William Bertrand is the Chief Operating Officer with a background in law and biology, known for his roles in major pharmaceutical companies and on several boards of directors.
William Bertrand, Chief Operating Officer
William Bertrand serves as the Chief Operating Officer. He has held multiple important roles in various pharmaceutical and biopharmaceutical companies, demonstrating a wealth of operational and corporate strategy experience.
General Counsel and Compliance Roles at MedImmune
William Bertrand began his tenure at MedImmune as the first General Counsel and Chief Compliance Officer. He played a critical role at the company, assuming various operational and corporate strategy responsibilities. His work at MedImmune positioned him as a key player in regulatory and compliance matters within the biopharmaceutical sector.
Executive Vice President at Infinity Pharmaceuticals
William Bertrand served as Executive Vice President and General Counsel at Infinity Pharmaceuticals, Inc. His legal expertise and executive leadership contributed to the company's strategic initiatives and regulatory compliance.
Leadership at Salix Pharmaceuticals
During his time at Salix Pharmaceuticals, William Bertrand held multiple leadership titles, including Senior Vice President, Acting Chief Operating Officer, and General Counsel. He played a pivotal role in the successful integration of Salix Pharmaceuticals' $14 billion acquisition by Valeant Pharmaceuticals in April 2015.
Board Member and Director Roles
Currently, William Bertrand is a member of the board of directors at Ardelyx, Inc. (Nasdaq: ARDX). Additionally, he has served on the boards of various private companies, including Trustwave and Inotek Pharmaceuticals. His board positions highlight his extensive governance experience within the pharmaceutical and technology sectors.
Educational Background
William Bertrand holds a J.D. from the University of Wisconsin and a B.S. in biology from Wayne State University. His educational qualifications provide a robust foundation for his roles in legal counsel and executive management within the pharmaceutical industry.